NYSE · traded in Congress
Stryker SYK
$330.2697 +4.3997 (+1.35%) Nov 9, 2026 4:33 AM ET
Chart
Analyst ratings
- 22 buy
- 9 hold
- 0 sell
Quarterly financials
| Quarter ended | Revenue | Gross profit | Net income | Net margin |
|---|---|---|---|---|
| $6,520M | $4,248M | $753M | 11.6% | |
| $6,589M | $4,498M | $1,276M | 19.4% | |
| $6,020M | $3,810M | $745M | 12.4% | |
| $7,171M | $4,628M | $849M | 11.8% |
New SEC filings
- 4 FORM 4 filed Nov 9, 2026
- 8-K 8-K filed Nov 9, 2026
All SYK filings on SEC EDGAR ›
Congress trades in SYK
Members of Congress disclosed 3 transactions in SYK in the filings we have processed.
| Traded | Member | Type | Amount | Filed |
|---|---|---|---|---|
| 09/30/2026 | Thomas H. Kean NJ07 | Partial sale | $1,001 - $15,000 | 10/30/2026 filing |
| 07/22/2026 | Thomas H. Kean NJ07 | Partial sale | $1,001 - $15,000 | 8/18/2026 filing |
| 06/02/2026 | Thomas H. Kean NJ07 | Partial sale | $1,001 - $15,000 | 7/15/2026 filing |
Disclosed under the STOCK Act. Amounts are the ranges the law requires, filings can lag a trade by up to 45 days, and a disclosure is not evidence of wrongdoing. All congressional trades ›
Other companies
Price and key figures from Nasdaq's public quote data, refreshed through the day; the chart is live from TradingView; options activity, ratings, financials, earnings and filings refreshed through the day. Congressional trades parsed from official House filings. Market information, not investment advice.

